Free Trial

Fennec Pharmaceuticals (FENC) Short Interest Ratio & Short Volume

$6.57
-0.13 (-1.94%)
(As of 07/24/2024 ET)

Fennec Pharmaceuticals Short Interest Data

Current Short Interest
1,800,000 shares
Previous Short Interest
1,770,000 shares
Change Vs. Previous Month
+1.69%
Dollar Volume Sold Short
$11.00 million
Short Interest Ratio
11.9 Days to Cover
Last Record Date
June 30, 2024
Outstanding Shares
27,330,000 shares
Float Size
22,600,000 shares
Short Percent of Float
7.96%
Today's Trading Volume
98,400 shares
Average Trading Volume
126,425 shares
Today's Volume Vs. Average
78%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Fennec Pharmaceuticals ?

Sign up to receive the latest short interest report for Fennec Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

FENC Short Interest Over Time

FENC Days to Cover Over Time

FENC Percentage of Float Shorted Over Time

Fennec Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
6/30/20241,800,000 shares $11.00 million +1.7%8.0%11.9 $6.11
6/15/20241,770,000 shares $11.97 million No Change7.8%11.8 $6.76
5/31/20241,770,000 shares $12.00 million +1.7%7.9%10.6 $6.78
5/15/20241,740,000 shares $12.15 million -3.9%7.5%10.4 $6.98
4/30/20241,810,000 shares $16.62 million -3.2%7.8%13.7 $9.18
4/15/20241,870,000 shares $19.32 million +3.3%8.1%14.5 $10.33
3/31/20241,810,000 shares $20.13 million +7.1%9.1%16.4 $11.12
3/15/20241,690,000 shares $16.80 million -1.2%8.5%14.4 $9.94
2/29/20241,710,000 shares $16.19 million -2.3%8.6%13.9 $9.47
2/15/20241,750,000 shares $16.00 million -2.2%8.9%14.8 $9.14
1/31/20241,790,000 shares $17.88 million -3.8%9.1%15.3 $9.99
1/15/20241,860,000 shares $19.14 million -7.5%9.5%15.3 $10.29
12/31/20232,010,000 shares $22.55 million -1.5%9.2%15.6 $11.22
12/15/20232,040,000 shares $20.30 million +6.8%9.4%15 $9.95
11/30/20231,910,000 shares $16.43 million -2.6%8.8%19.1 $8.60
11/15/20231,960,000 shares $15.70 million +2.1%9.0%20.9 $8.01
10/31/20231,920,000 shares $13.21 million -0.5%8.7%23 $6.88
10/15/20231,930,000 shares $13.32 million +19.1%8.8%25.4 $6.90
9/30/20231,620,000 shares $12.17 million +1.3%7.4%22.7 $7.51
9/15/20231,600,000 shares $12.69 million -3.0%7.3%27.3 $7.93
8/31/20231,650,000 shares $13.46 million -0.6%7.5%15.2 $8.16
8/15/20231,660,000 shares $13.76 million +0.6%7.6%14.5 $8.29
7/31/20231,650,000 shares $14.70 million -2.9%7.5%13.3 $8.91
7/15/20231,700,000 shares $14.93 million -1.2%7.8%13.8 $8.78
6/30/20231,720,000 shares $15.19 million -1.2%7.9%13.6 $8.83
6/15/20231,740,000 shares $16.84 million +1.2%8.0%12.6 $9.68
5/31/20231,720,000 shares $13.04 million +17.0%7.9%19.1 $7.58
5/15/20231,470,000 shares $11.23 million No Change6.7%17 $7.64
10/31/2022547,400 shares $4.82 million +17.4%2.9%3.6 $8.80
10/15/2022466,300 shares $3.67 million -6.3%2.4%3.3 $7.87
9/30/2022497,800 shares $4.03 million +1.1%2.6%3.9 $8.10
9/15/2022492,200 shares $3.31 million +39.7%2.6%4.3 $6.72
8/31/2022352,300 shares $2.47 million +16.2%1.6%7.1 $7.00
8/15/2022303,100 shares $2.06 million +64.7%1.4%8 $6.79
7/31/2022184,000 shares $1.23 million +18.3%0.9%6.3 $6.68
7/15/2022155,500 shares $1.04 million -1.3%0.7%5.3 $6.72
6/30/2022157,600 shares $879,408.00 -25.5%1.0%5.5 $5.58
6/15/2022211,400 shares $1.19 million -18.0%1.3%7.2 $5.61
5/31/2022257,900 shares $1.47 million -2.7%1.2%8 $5.71
5/15/2022265,100 shares $1.46 million -0.1%1.2%7.5 $5.52
Next opportunity for crypto millions (Ad)

The Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has led to a massive bull run in the year after it happens. That means we're in the "golden window" right now…

Check out the new "Crypto Bull Run Millionaire Blueprint" now!
4/30/2022265,300 shares $1.53 million -1.7%1.2%7.2 $5.78
4/15/2022269,800 shares $1.67 million -0.4%1.3%6.8 $6.20
3/31/2022270,800 shares $1.52 million -3.3%N/A5.9 $5.60
3/15/2022279,900 shares $1.46 million -0.7%1.3%4.8 $5.20
2/28/2022281,800 shares $1.58 million -5.8%1.3%4.1 $5.59
2/15/2022299,200 shares $1.45 million +2.6%1.4%2.1 $4.86
1/31/2022291,500 shares $1.36 million -7.5%1.4%1.9 $4.65
1/15/2022315,100 shares $1.46 million +4.0%N/A0 $4.63
12/31/2021302,900 shares $1.33 million -15.8%1.4%2 $4.40
12/15/2021359,700 shares $1.54 million -13.8%1.7%2.5 $4.28
11/30/2021417,400 shares $1.83 million -7.0%1.9%3.2 $4.39
11/15/2021448,900 shares $4.33 million -5.8%2.1%8.2 $9.65
10/29/2021476,400 shares $4.41 million +8.0%2.2%10.3 $9.26
10/15/2021441,000 shares $4.05 million -4.2%2.0%10.7 $9.19
9/30/2021460,400 shares $4.34 million -16.0%2.1%10 $9.42
9/15/2021547,800 shares $4.73 million -9.4%2.5%5.3 $8.64
8/31/2021604,900 shares $4.79 million -8.0%2.8%5 $7.92
8/13/2021657,800 shares $4.69 million -8.6%3.0%4.8 $7.13
7/30/2021719,300 shares $4.68 million -1.6%3.3%4.9 $6.51
7/15/2021731,300 shares $4.83 million +3.9%3.4%4.5 $6.61
6/30/2021703,700 shares $5.13 million -50.4%3.3%4.2 $7.29
6/15/20211,420,000 shares $9.40 million +3.7%6.6%9.9 $6.62
5/28/20211,370,000 shares $10.10 million -6.2%6.3%10.8 $7.37
5/14/20211,460,000 shares $9.05 million +2.8%6.7%12.5 $6.20
4/30/20211,420,000 shares $9.23 million +14.5%6.6%12.5 $6.50
4/15/20211,240,000 shares $8.00 million +14.8%N/A0 $6.45
3/31/20211,080,000 shares $6.97 million +8.0%5.6%10.4 $6.45
3/15/20211,000,000 shares $7.70 million +3.3%5.2%12.5 $7.70
2/26/2021967,900 shares $7.39 million +6.2%5.0%11.4 $7.64
2/12/2021911,300 shares $7.63 million +1.0%4.7%10.1 $8.37
1/29/2021902,600 shares $6.64 million -8.2%4.7%8.9 $7.36
1/15/2021983,200 shares $7.27 million -1.2%5.1%9.2 $7.39
12/31/2020994,700 shares $7.10 million -5.3%5.2%9.2 $7.14
12/15/20201,050,000 shares $7.95 million -13.2%5.4%7.9 $7.58
11/30/20201,210,000 shares $9.37 million -4.7%6.3%7.5 $7.74
11/15/20201,270,000 shares $10.86 million -5.9%6.6%6.7 $8.55
10/30/20201,350,000 shares $10.42 million +7.1%7.0%5.2 $7.72
10/15/20201,260,000 shares $9.25 million -10.0%6.7%3.2 $7.34
9/30/20201,400,000 shares $8.48 million +1.5%7.4%3.4 $6.06
9/15/20201,380,000 shares $8.42 million +17.0%7.3%2.9 $6.10
8/31/20201,180,000 shares $6.47 million +11.3%6.3%2.5 $5.48
8/14/20201,060,000 shares $6.01 million -4.5%5.6%2.4 $5.67
7/31/20201,110,000 shares $9.37 million -9.0%5.2%3 $8.44
7/15/20201,220,000 shares $10.35 million -10.3%5.7%4.8 $8.48
6/30/20201,360,000 shares $11.12 million +164.4%6.4%6 $8.18
6/15/2020514,400 shares $4.32 million -6.2%2.4%3.4 $8.39
5/29/2020548,400 shares $4.06 million +2.6%2.7%4.5 $7.40
5/15/2020534,300 shares $3.92 million -20.7%2.7%4.9 $7.34
4/30/2020673,700 shares $4.87 million -2.5%3.4%6.4 $7.23
4/15/2020691,100 shares $4.38 million -19.0%4.2%10.1 $6.34
Next opportunity for crypto millions (Ad)

The Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has led to a massive bull run in the year after it happens. That means we're in the "golden window" right now…

Check out the new "Crypto Bull Run Millionaire Blueprint" now!
3/31/2020852,900 shares $6.46 million +27.8%5.2%12.7 $7.58
3/13/2020667,400 shares $4.31 million -0.4%4.1%9.5 $6.46
2/28/2020670,200 shares $3.53 million +19.9%4.1%12.1 $5.26
2/14/2020559,000 shares $3.78 million +15.2%3.4%11.3 $6.76
1/31/2020485,400 shares $3.23 million -2.8%3.0%12.1 $6.65
1/15/2020499,300 shares $3.58 million +6.4%3.0%13.4 $7.17
12/31/2019469,400 shares $2.87 million +10.5%2.9%14.2 $6.12

FENC Short Interest - Frequently Asked Questions

What is Fennec Pharmaceuticals' current short interest?

Short interest is the volume of Fennec Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of June 30th, investors have sold 1,800,000 shares of FENC short. 7.96% of Fennec Pharmaceuticals' shares are currently sold short. Learn More on Fennec Pharmaceuticals' current short interest.

What is a good short interest ratio for Fennec Pharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. FENC shares currently have a short interest ratio of 12.0. Learn More on Fennec Pharmaceuticals's short interest ratio.

What is a good short interest percentage for Fennec Pharmaceuticals?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 7.96% of Fennec Pharmaceuticals' floating shares are currently sold short.

Is Fennec Pharmaceuticals' short interest increasing or decreasing?

Fennec Pharmaceuticals saw a increase in short interest during the month of June. As of June 30th, there was short interest totaling 1,800,000 shares, an increase of 1.7% from the previous total of 1,770,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Fennec Pharmaceuticals' float size?

Fennec Pharmaceuticals currently has issued a total of 27,330,000 shares. Some of Fennec Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Fennec Pharmaceuticals currently has a public float of 22,600,000 shares.

How does Fennec Pharmaceuticals' short interest compare to its competitors?

7.96% of Fennec Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Fennec Pharmaceuticals: Scholar Rock Holding Co. (16.75%), Ginkgo Bioworks Holdings, Inc. (8.53%), Exscientia plc (3.15%), REGENXBIO Inc. (8.77%), Replimune Group, Inc. (12.65%), Adaptive Biotechnologies Co. (8.24%), Allogene Therapeutics, Inc. (30.27%), iTeos Therapeutics, Inc. (9.39%), Alector, Inc. (5.69%), Valneva SE (0.11%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($3.71 billion), TC Energy Co. ($2.95 billion), Moderna, Inc. ($2.63 billion), Royal Caribbean Cruises Ltd. ($2.53 billion), Paychex, Inc. ($2.03 billion), Cencora, Inc. ($2.03 billion), Tractor Supply ($1.91 billion), Rivian Automotive, Inc. ($1.78 billion), Chesapeake Energy Co. ($1.50 billion), and United Therapeutics Co. ($1.40 billion). View all of the most shorted stocks.

What does it mean to sell short Fennec Pharmaceuticals stock?

Short selling FENC is an investing strategy that aims to generate trading profit from Fennec Pharmaceuticals as its price is falling. FENC shares are trading down $0.13 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Fennec Pharmaceuticals?

A short squeeze for Fennec Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of FENC, which in turn drives the price of the stock up even further.

How often is Fennec Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including FENC, twice per month. The most recent reporting period available is June, 30 2024.



This page (NASDAQ:FENC) was last updated on 7/25/2024 by MarketBeat.com Staff

From Our Partners